Using in-country comparables to measure the returns due to pharmaceutical marketing and distribution affiliates

The importance of using in-country comparables by highlighting the market variations that exist for pharmaceutical marketing/distribution entities operating in France, Germany, Italy, Spain and the United Kingdom, is demonstrated.